image
PetMed Express, Inc. PETS
Healthcare - Medical - Pharmaceuticals - NASDAQ - US
Watchlist
$ 3.29
-2.37 %
$ 68 M
Market Cap
329.0
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one PETS stock under the worst case scenario is HIDDEN Compared to the current market price of 3.29 USD, PetMed Express, Inc. is HIDDEN

PETS Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one PETS stock under the base case scenario is HIDDEN Compared to the current market price of 3.29 USD, PetMed Express, Inc. is HIDDEN

PETS Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one PETS stock under the best case scenario is HIDDEN Compared to the current market price of 3.29 USD, PetMed Express, Inc. is HIDDEN

PETS Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart PETS

image
1M -21%
6M -47%
1Y -18%
3Y -524%
5Y -874%
All
$5.5$5.5$5.0$5.0$4.5$4.5$4.0$4.0$3.5$3.5$3.0$3.020252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25
FINANCIALS
281 M REVENUE
9.42%
Growth Rates
1Year 9.42%
3Years -3.13%
5Years -0.17%
7Years 1.74%
10Years 1.88%
-8.16 M OPERATING INCOME
-470.77%
Growth Rates
1Year -470.77%
3Years -6.77%
5Years -3.31%
7Years -2.85%
10Years -2.57%
-7.46 M NET INCOME
-3203.43%
Growth Rates
1Year -3203.43%
3Years -7.55%
5Years -3.68%
7Years -3.97%
10Years -3.53%
4.32 M OPERATING CASH FLOW
-84.47%
Growth Rates
1Year -84.47%
3Years -52.42%
5Years -37.46%
7Years -28.94%
10Years -10.78%
-40.7 M INVESTING CASH FLOW
-296.39%
Growth Rates
1Year -296.39%
3Years -155.72%
5Years -130.87%
7Years -21.17%
10Years -77.77%
-12.4 M FINANCING CASH FLOW
49.31%
Growth Rates
1Year 49.31%
3Years 18.16%
5Years 10.72%
7Years 3.10%
10Years 0.61%
53 M REVENUE
-11.06%
Growth Rates
1Year 9.42%
3Years -3.13%
5Years -0.17%
7Years 1.74%
10Years 1.88%
-450 K OPERATING INCOME
-81.23%
Growth Rates
1Year -470.77%
3Years -6.77%
5Years -3.31%
7Years -2.85%
10Years -2.57%
-707 K NET INCOME
-30.40%
Growth Rates
1Year -3203.43%
3Years -7.55%
5Years -3.68%
7Years -3.97%
10Years -3.53%
-1.17 M OPERATING CASH FLOW
-15.78%
Growth Rates
1Year -84.47%
3Years -52.42%
5Years -37.46%
7Years -28.94%
10Years -10.78%
-777 K INVESTING CASH FLOW
38.58%
Growth Rates
1Year -296.39%
3Years -155.72%
5Years -130.87%
7Years -21.17%
10Years -77.77%
-1 K FINANCING CASH FLOW
98.59%
Growth Rates
1Year 49.31%
3Years 18.16%
5Years 10.72%
7Years 3.10%
10Years 0.61%
Balance Sheet PetMed Express, Inc.
image
Current Assets 93.6 M
Cash & Short-Term Investments 55.3 M
Receivables 3.28 M
Other Current Assets 35.1 M
Non-Current Assets 76.2 M
Long-Term Investments 5.3 M
PP&E 28.1 M
Other Non-Current Assets 42.8 M
32.55 %20.64 %3.12 %16.53 %25.22 %Total Assets$169.9m
Current Liabilities 72.2 M
Accounts Payable 37 M
Short-Term Debt 459 K
Other Current Liabilities 34.7 M
Non-Current Liabilities 995 K
Long-Term Debt 995 K
Other Non-Current Liabilities 0
50.61 %47.40 %Total Liabilities$73.2m
EFFICIENCY
Earnings Waterfall PetMed Express, Inc.
image
Revenue 281 M
Cost Of Revenue 202 M
Gross Profit 78.6 M
Operating Expenses 86.8 M
Operating Income -8.16 M
Other Expenses -698 K
Net Income -7.46 M
300m300m250m250m200m200m150m150m100m100m50m50m00(50m)(50m)281m(202m)79m(87m)(8m)698k(7m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
27.98% GROSS MARGIN
27.98%
Averages
1Year 27.98%
3Years 28.06%
5Years 28.37%
7Years 30.17%
10Years 30.88%
-2.90% OPERATING MARGIN
-2.90%
Averages
1Year -2.90%
3Years 1.98%
5Years 5.80%
7Years 9.19%
10Years 10.52%
-2.66% NET MARGIN
-2.66%
Averages
1Year -2.66%
3Years 1.43%
5Years 4.22%
7Years 6.86%
10Years 7.40%
-7.72% ROE
-7.72%
Averages
1Year -7.72%
3Years 1.88%
5Years 8.49%
7Years 14.67%
10Years 17.61%
-4.39% ROA
-4.39%
Averages
1Year -4.39%
3Years 2.12%
5Years 7.15%
7Years 12.55%
10Years 15.28%
-9.89% ROIC
-9.89%
Averages
1Year -9.89%
3Years 1.32%
5Years 8.51%
7Years 14.23%
10Years 17.21%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis PetMed Express, Inc.
image
45m45m40m40m35m35m30m30m25m25m20m20m15m15m10m10m5m5m00(5m)(5m)201620162017201720182018201920192020202020212021202220222023202320242024
Net Income -7.46 M
Depreciation & Amortization 7.06 M
Capital Expenditures -4.51 M
Stock-Based Compensation 6.87 M
Change in Working Capital -2.76 M
Others -379 K
Free Cash Flow -194 K
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets PetMed Express, Inc.
image
Wall Street analysts predict an average 1-year price target for PETS of $13.2 , with forecasts ranging from a low of $7 to a high of $20 .
PETS Lowest Price Target Wall Street Target
7 USD 112.77%
PETS Average Price Target Wall Street Target
13.2 USD 302.74%
PETS Highest Price Target Wall Street Target
20 USD 507.90%
Price
Max Price Target
Min Price Target
Average Price Target
20201818161614141212101088664422Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0.3 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
1.401.401.201.201.001.000.800.800.600.600.400.400.200.200.000.000.170.180.190.250.270.270.280.30.30.180.190.20.250.270.280.30.30.30.180.190.20.270.270.280.30.30.30.180.710.190.750.20.790.271.040.271.080.281.110.31.180.31.200.90201520152016201620172017201820182019201920202020202120212022202220232023
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 5
6. Ownership
Insider Ownership PetMed Express, Inc.
image
Sold
0-3 MONTHS
200 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
1.92 K USD 1
Bought
224 K USD 2
0-3 MONTHS
1.52 M USD 1
3-6 MONTHS
728 K USD 2
6-9 MONTHS
41.8 K USD 1
9-12 MONTHS
7. News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS).  Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. 7980. globenewswire.com - 2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ:PETS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accessnewswire.com - 2 weeks ago
PetMed Express, Inc. Announces Preliminary Fourth Quarter and FY 2025 Results and Filing of Form 12b-25 DELRAY BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced preliminary fourth quarter and fiscal year 2025 results and filed Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission. The Company is unable to file its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 within the prescribed time period without unreasonable effort or expense. The Company expects to file its Annual Report on Form 10-K with the Securities and Exchange Commission as soon as practicable, and no later than July 1, 2025, in accordance with Rule 12b-25. globenewswire.com - 2 weeks ago
Markets Keep Nudging Higher Ahead of Trade Deals, CPI The S&P 500 is now at its highest level since February 20th. zacks.com - 3 weeks ago
PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call DELRAY BEACH, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced it is delaying the release of the Company's fourth quarter and fiscal year 2025 earnings release and subsequent conference call, which had been scheduled for June 10, 2025, because the Company requires additional time to complete the year-end audit process. globenewswire.com - 3 weeks ago
Pets at Home follows guidance perfectly Pets at Home Group PLC (LSE:PETS) posted profits bang in line with expectations and reiterated its guidance for the year ahead.  The pet store and veterinary services chain reported flat statutory revenue of £1.5 billion for the year to 27 March 2025, with statutory profit before tax rising 14% to £120.6 million. proactiveinvestors.co.uk - 1 month ago
PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call DELRAY BEACH, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) will hold a conference call on Tuesday, June 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fourth quarter and full fiscal year ended March 31, 2025. globenewswire.com - 1 month ago
PetMed Express, Inc. and Dutch Announce Partnership to Provide Accessible Telehealth Services for Pets Strategic Collaboration Marks PetMeds' Latest Move in Expanding Its Pet Healthcare Ecosystem Strategic Collaboration Marks PetMeds' Latest Move in Expanding Its Pet Healthcare Ecosystem globenewswire.com - 1 month ago
PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th DELRAY BEACH, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- In celebration of National Pet Day, PetMed Express, Inc. (NASDAQ: PETS)—the original consumer pet healthcare company serving dogs, cats, and horses for nearly 30 years—will ring the Nasdaq Opening Bell this Friday, April 11, 2025. globenewswire.com - 2 months ago
PetMed Express, Inc. Announces Appointment of Peter Batushansky to Board of Directors Former pet industry executive with more than 20 years of experience across retail, pet, healthcare, and private equity Third independent director to join the Board since 2024 Longtime board member and former Chairman Dr. Gian Fulgoni will retire DELRAY BEACH, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., parent company of PetMeds and PetCareRx, (Nasdaq: PETS) (the "Company") today announced the appointment of Peter Batushansky to the Company's Board of Directors (“the Board”), effective April 09, 2025. globenewswire.com - 2 months ago
Pets at Home falls 8.7% amid NI headwind and consumer caution; brokers unsurprised Pets at Home Group PLC (LSE:PETS) shares fell 8.7% on Monday after the retailer lowered its profit forecast for the year ahead, blaming rising costs and continued consumer caution. The group now expects underlying pre-tax profit for the next financial year to fall to between £115 million and £125 million, down from this year's expected £133 million. proactiveinvestors.co.uk - 3 months ago
Pets at Home tumbles on warning of lower profits for year ahead Pets at Home Group PLC (LSE:PETS) shares dropped 11.3% after the retailer and vet chain reported trading in line with expectations but gave weak guidance for the new financial year.  A pre-close trading update from the FTSE 250-listed group revealed a "challenging and volatile UK consumer backdrop" but that fourth-quarter trading in both the Retail and Vets businesses was broadly as expected. proactiveinvestors.co.uk - 3 months ago
8. Profile Summary

PetMed Express, Inc. PETS

image
COUNTRY US
INDUSTRY Medical - Pharmaceuticals
MARKET CAP $ 68 M
Dividend Yield 0.00%
Description PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Contact 420 South Congress Avenue, Delray Beach, FL, 33445 https://www.1800petmeds.com
IPO Date April 26, 1999
Employees 287
Officers Ms. Robyn DElia Chief Financial Officer Mr. Doug Krulik Chief Accounting Officer Ms. Jacqueline Smith Vice President of People Ms. Carla Dodds Chief Marketing Officer Wendy Zalai Corporate Controller & Corporate Secretary Mr. Umesh Sripad Chief Digital & Technology Officer Ms. Sandra Y. Campos President, Chief Executive Officer & Director Ms. Caroline Conegliano Chief Operating Officer